AQC-Pattern Accordion-Collapse Accordion-Expand Agenda-Map CROs Consulting Download Email Fax Filter-Check Filter-Remove LinkedIn Map-Pin Member-Login Pharma-Biotech-Devices Phone Summit-Registration Survey-Research The-Avoca-Group-Consulting-And-Research-Services-Horizontal The-Avoca-Group-Diligent-Prequalification-Platform-Horizontal The-Avoca-Group-Quality-Consortium-Horizontal Training avoca-logo-coloravoca-logo-graycheckconsulting_logo2 diligent_logo2 dots dotted-01 dotted down-arrow GroupCreated with Sketch. minus plus quality_logo2 right-arrow twitter

2023 Avoca Industry Report: 360° Assessment


For more than 20 years, Avoca has surveyed industry executives to gain an understanding of key trends affecting outsourced clinical development. Given that only a very small population of physicians and patients contribute to what we know about motivations and impediments toward clinical trial participation, this year’s research expanded outreach to look across all clinical research stakeholders — Sponsors, Providers, Site Staff, and Patients — regardless of their clinical trial experience, to identify opportunities for improvement of the experience for Patients and Sites.

Industry and regulatory focus on patient centricity is imperative to ensure the survival of the clinical trial industry.  Most Sponsor and Provider organizations base their study designs on feedback from investigators and patients who are familiar with the clinical trial industry.  In order to expand the patient pool for clinical research, Sponsors must develop protocols that meet the needs of research-naïve patients and investigators.

This report summarizes key findings to provide a 360° view on motivators and deterrents to clinical trial participation to inform decisions as we progress forward allocating resources and focus in the areas that have the greatest impact on encouraging clinical trial participation.


Access Report ››



Click here to access The 2023 WCG Avoca State of the Industry Report: A 360° Assessment of the Clinical Trial Industry, as well as Avoca’s past research reports.




Webinar Recording:
“Implementing ICH E8 R1 Recommendations Increases Site and Participant Relationship Scoring Measures”
View Now ››

WCG’s 360 Protocol Assessment™ – an integrated, turn-key solution that improves clinical trial predictability
Learn More ››